Collecting and Storing Blood Samples From Patients With Cancer

Withdrawn

• Conditions: Leukemia; Myelodysplastic Syndromes; Lymphoproliferative Disorder; Myelodysplastic/Myeloproliferative Neoplasms; Lymphoma; Brain and Central Nervous System Tumors; Unspecified Adult Solid Tumor, Protocol Specific; Chronic Myeloproliferative Disorders; Multiple Myeloma and Plasma Cell Neoplasm; Nonmalignant Neoplasm

• Registration Number: NCT00900120
• Lead Sponsor: University of Medicine and Dentistry of New Jersey

Brief Summary

RATIONALE: Collecting and storing samples of blood from patients with cancer to test in the laboratory may help the study of cancer in the future.

PURPOSE: This research study is collecting and storing blood samples from patients with cancer.

Detailed Description

OBJECTIVES:

* To establish a repository for long-term storage of DNA obtained from patients treated at the Cancer Institute of New Jersey.

* To establish a mechanism whereby investigators can analyze correlations between genetic polymorphisms and clinical outcomes (e.g., response to treatment).

OUTLINE: Additional blood samples are collected for banking from patients while they are scheduled for routine blood draw as a part of their normal care. Samples are stored in a secure place under the control of the Cancer Institute of New Jersey Tissue Retrieval service. The samples may be used for DNA, RNA, or protein extraction and analyses, as well as generation of cell lines.

Demographic data (ethnicity, race, age, and sex), diagnosis, family history, and previous treatments (chemotherapy, radiation, and surgery) are recorded on the case report form and kept in a secure location in the Office of Human Research Services (OHRS).

Patients may have their samples removed and destroyed at any time.

Study Timeline

• Study Start: 2004-03
• Study First Submitted: 2009-05-09
• Study First Submitted QC: 2009-05-09
• Study First Posted: 2009-05-12
• Primary Completion: 2011-05
• Study Completion: 2011-05
• Status Verified: 2021-09
• Last Update Submitted: 2021-09-20
• Last Update Posted: 2021-09-21

Recruitment & Eligibility

• Status: WITHDRAWN
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
DNA repository for long-term storage of DNA obtained from patients treated at the Cancer Institute of New Jersey	Indefinite
Investigative mechanism to allow correlations between genetic polymorphisms and clinical outcomes	Indefinite